- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr. Thomas Graf Discusses Geisinger's Improved Quality Scores in CMS' 5-Year Demonstration Project
Dr. Thomas Graf, Associate Chief Medical Officer, Population Health, Geisinger Health System, Danville, PA, who also serves as Chairman, Community Practice at Geisinger, discusses the health system’s participation in the Centers for Medicare Services’ 5-year Physician Group Practice (PGP) transitions demonstration project.
In addition, Dr. Graf also discusses Geisinger's improved quality scores during the pilot program, the out-of-control medical costs, and how the accountable care organization (ACO) model represents the best opportunity for transitioning healthcare from a volume-based to a value-based system.
Specialty Drug Users to Gain Relief Under Medicare Reforms
May 16th 2025A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often represent a significant cost burden for Medicare Part D beneficiaries and which were selected for 2026 drug price negotiation under the Inflation Reduction Act.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits
May 15th 2025Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.
Read More
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More
